Albumin for kidney recovery after ICU kidney injury
Treatments studied
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether giving albumin (a blood protein through an IV) can improve recovery after acute kidney injury in people who are in the ICU and need kidney support treatment. It mainly aims to help the kidneys bounce back better after this serious illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been in an ICU/critical care unit for more than 24 hours.
- You are on IV medicines to support blood pressure (vasoactive therapy) and/or you are on a breathing machine (mechanical ventilation, including non-invasive).
- Your care team plans to start kidney replacement therapy (RRT) right away for acute kidney injury, or you will need extra RRT sessions soon.
- You have not already had 2 or more RRT sessions during this ICU stay.
- You do not have serious liver failure or certain other kidney problems (like suspected blockage or specific immune/rapid-scarring kidney diseases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial studies two ways of giving albumin (a protein given through an IV) to people with cirrhosis who also have a sudden kidney injury from sepsis. The goal is to see which method—tailored to each patient or a fixed dose—is safer and works better for kidney recovery.
This trial tests whether giving albumin (a protein in the blood) along with standard fluids helps patients with septic shock after a surgical infection. The goal is to see if it improves recovery and survival compared to fluids alone.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This trial tests if a drug called vasopressin can help prevent acute kidney injury in patients at high risk. It's for adults in the ICU who have a predicted risk score of 5 or higher based on their lab and health data.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.